Loading...
Please wait, while we are loading the content...
Similar Documents
Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
| Content Provider | Scilit |
|---|---|
| Author | Gawrieh, Samer Chalasani, Naga |
| Copyright Year | 2018 |
| Description | Journal: Clinics in Liver Disease This review discusses completed phase II randomized clinical trials with high-quality published results for compounds that demonstrate effects on nonalcoholic steatohepatitis histology (obeticholic acid, elafibranor, and liraglutide). The authors also review the available preliminary data on cenicriviroc and selonsertib, with or without simtuzumab's phase II studies. Finally, the authors briefly discuss compounds that have been tested but did not achieve the primary end point of histologic improvement and appeared in high-quality published articles (cysteamine bitartrate and long-chain polyunsaturated fatty acids). |
| Related Links | https://scholarworks.iupui.edu/bitstream/1805/16121/1/Gawrieh_20217_emerging.pdf |
| Ending Page | 199 |
| Page Count | 11 |
| Starting Page | 189 |
| ISSN | 10893261 |
| e-ISSN | 15578224 |
| DOI | 10.1016/j.cld.2017.08.013 |
| Journal | Clinics in Liver Disease |
| Issue Number | 1 |
| Volume Number | 22 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2018-02-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Clinics in Liver Disease Gastroenterology and Hepatology |
| Content Type | Text |
| Resource Type | Article |
| Subject | Hepatology |